Dishman Carbogen Amcis’ wholly owned subsidiary namely CARBOGEN AMCIS AG., Switzerland has entered into joint funding agreement with a longstanding Japan based customer to build a site extension at the Bubendorf site in Switzerland. The expansion will be created adjacent to an existing manufacturing facility on the Bubendorf Switzerland Site. This important expansion will incorporate a new production line comprising of two 850 L reactors and one agitated filter drier. The facility is designed for highly potent manufacturing up to category 4 (OEL of 1 µg/m³ and lower).
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
